Target intelligence / Profile preview

Immunoglobulin heavy variable (III)-26-1 (IGHVIII-26-1)

Target
IGHVIII-26-1
Molecular classification
Other (pseudogene; not a receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

Immunoglobulin heavy variable (III)-26-1 is a human pseudogene belonging to the immunoglobulin heavy chain variable region family. Unlike functional immunoglobulin variable region genes—which encode the variable domains of immunoglobulin heavy chains (critical for antigen recognition in antibodies)[1][5][6]—IGHVIII-26-1 does not encode a functional protein and is not expressed in B lymphocytes or incorporated into mature immunoglobulins. The immunoglobulin heavy chain locus (IGH) contains multiple variable, diversity, and joining gene segments (V, D, J), some of which are functional and some pseudogenes. IGHVIII-26-1 is among the latter and contributes no direct function to antibody generation or immune response[2][4][6]. The main evidence supporting pseudogene status comes from genomic databases (GeneCards, Merck Millipore)[2][4] and immunogenetics reference tables[6], which list IGHVIII-26-1 as "pseudogene" (often with the suffix P, e.g. 3-26.1P), and do not associate it with any functional immunoglobulin heavy chain protein. No drugs, biomarkers, or therapeutic relevance are tied to IGHVIII-26-1. If a therapeutic or research context refers to IGHVIII-26-1 as a protein target, this would be scientifically incorrect.

Other names
IGHV(III)-26-13-26.1PIGHVIII261IGHVIII-26-1
02

Mechanism of action

Null (no mechanism because there are no interacting drugs)

03

Biological functions

None as a pseudogene; does not produce a functional protein
04

Disease associations

None established (no known disease association or functional role)
05

Safety considerations

None (no clinical safety concerns as it is not a therapeutic or diagnostic target)
06

Interacting drugs

None (no drugs target this pseudogene)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on Immunoglobulin heavy variable (III)-26-1 (IGHVIII-26-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable (III)-26-1 (IGHVIII-26-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call